AssetMark Inc
LKFT

AssetMark Inc’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

AssetMark Inc’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.67K Buy
256
+231
+924% +$6.56K ﹤0.01% 2548
2026
Q1 		$750 Buy
25
+3
+14% +$99 ﹤0.01% 3096
2025
Q4 		$719 Sell
22
-20
-48% -$646 ﹤0.01% 3021
2025
Q3 		$1.46K Buy
42
+30
+250% +$960 ﹤0.01% 2701
2025
Q2 		$336 Buy
+12
New +$322 ﹤0.01% 2804
2021
Q4 		– Sell
-171
Closed -$9K – 1561
2021
Q3 		$9K Hold
171
– – ﹤0.01% 1064
2021
Q2 		$12K Sell
171
-641
-79% -$48.9K ﹤0.01% 964
2021
Q1 		$63K Sell
812
-2,539
-76% -$234K ﹤0.01% 695
2020
Q4 		$332K Sell
3,351
-3,447
-51% -$422K ﹤0.01% 492
2020
Q3 		$965K Buy
6,798
+902
+15% +$150K 0.01% 336
2020
Q2 		$1.16M Buy
5,896
+453
+8% +$93.8K 0.01% 317
2020
Q1 		$1.07M Buy
5,443
+5,335
+4,940% +$1.15M 0.01% 312
2019
Q4 		$22K Sell
108
-14
-11% -$2.59K ﹤0.01% 911
2019
Q3 		$19K Buy
+122
New +$20K ﹤0.01% 888

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

AssetMark Inc's LKFT Position: Q2 2026 in Review

AssetMark Inc increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 924% in Q2 2026, buying an estimated $6.56K and bringing the position to 256 shares worth $7.67K. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

AssetMark Inc first reported a position in LKFT in Q3 2019 and has held it in 14 quarters since. The position peaked at $1.16M in Q2 2020. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • AssetMark Inc held 256 shares of Lakefront Biotherapeutics American Depositary Shares worth $7.67K as of Q2 2026.
  • AssetMark Inc bought 231 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $6.56K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #2548 holding.
  • AssetMark Inc first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2019 and has held it in 14 quarters since.
  • AssetMark Inc's Lakefront Biotherapeutics American Depositary Shares position peaked at $1.16M in Q2 2020.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.